Multiple drug hypersensitivity syndrome (MDH) should not be diagnosed by drug provocation tests

Affiliations

¹ Department of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: lukas.joerg@insel.ch.
² Department of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
³ ADR-AC GmbH, Adverse Drug Reactions, Analysis and Consulting, Bern, Switzerland.

Comment

Lukas Jörg et al. J Allergy Clin Immunol Pract. 2020 Feb.

. 2020 Feb;8(2):822-823.

doi: 10.1016/j.jaip.2019.10.050.

¹ Department of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: lukas.joerg@insel.ch.
² Department of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
³ ADR-AC GmbH, Adverse Drug Reactions, Analysis and Consulting, Bern, Switzerland.

No abstract available

Comment in

Reply.
Corren J. Corren J. J Allergy Clin Immunol Pract. 2020 Feb;8(2):822. doi: 10.1016/j.jaip.2019.11.025. J Allergy Clin Immunol Pract. 2020. PMID: 32037117 No abstract available.

Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.
Corren J, Castro M, O'Riordan T, Hanania NA, Pavord ID, Quirce S, Chipps BE, Wenzel SE, Thangavelu K, Rice MS, Harel S, Jagerschmidt A, Khan AH, Kamat S, Maroni J, Rowe P, Lu Y, Amin N, Pirozzi G, Ruddy M, Graham NMH, Teper A. Corren J, et al. J Allergy Clin Immunol Pract. 2020 Feb;8(2):516-526. doi: 10.1016/j.jaip.2019.08.050. Epub 2019 Sep 12. J Allergy Clin Immunol Pract. 2020. PMID: 31521831 Clinical Trial.